Eli Lilly (LLY) EBITDA (2009 - 2026)
Eli Lilly's EBITDA came in at $12.29 billion for Q2 2026, up 63.9% from $7.5 billion a year earlier and up 22.8% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EBITDA (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Eli Lilly reported EBITDA of $40.28 billion, up 68.7% year-over-year; for FY2025, it came in at $31.21 billion, up 73.9% from FY2024.
- EBITDA has increased in each of the last five years, with a five-year compound annual growth rate of 30.8% (FY2020 to FY2025).
- Going back by year, EBITDA was $17.95 billion in FY2024 (+52.3%), $11.78 billion in FY2023 (+23.3%), $9.56 billion in FY2022 (+7.7%) and $8.87 billion in FY2021 (+8.9%).
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q1 2009.
- Year-over-year, EBITDA has increased for 13 consecutive quarters, with growth averaging 67.4% over the last eight quarters.
- The fastest year-over-year change in EBITDA over five years came in Q1 2025 (growth of 89.7%), and the weakest in Q1 2023 (a decline of 34.7%).
- Business Quant data shows LLY's EBITDA at $10.01 billion (Q1 2026), $9.49 billion (Q4 2025) and $8.49 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Vertex Pharmaceuticals | 130.00 Bn | 102.01 Bn | 2.84 Bn | 1.30 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.29 Bn |
| Mar 31, 2026 | 10.01 Bn |
| Dec 31, 2025 | 9.49 Bn |
| Sep 30, 2025 | 8.49 Bn |
| Jun 30, 2025 | 7.50 Bn |
| Mar 31, 2025 | 5.73 Bn |
| Dec 31, 2024 | 5.82 Bn |
| Sep 30, 2024 | 4.82 Bn |
| Jun 30, 2024 | 4.28 Bn |
| Mar 31, 2024 | 3.02 Bn |
| Dec 31, 2023 | 3.40 Bn |
| Sep 30, 2023 | 3.84 Bn |
| Jun 30, 2023 | 2.59 Bn |
| Mar 31, 2023 | 1.96 Bn |
| Dec 31, 2022 | 2.45 Bn |
| Sep 30, 2022 | 2.10 Bn |
| Jun 30, 2022 | 2.00 Bn |
| Mar 31, 2022 | 3.01 Bn |
| Dec 31, 2021 | 2.80 Bn |
| Sep 30, 2021 | 2.44 Bn |
API Access
Eli Lilly EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();